Standout Papers

Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage p... 2017 2026 2020 2023 385
  1. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts (2017)
    Tsung‐Ming Lee, Nen‐Chung Chang et al. Free Radical Biology and Medicine

Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
2 intermediate papers

Works of Nen‐Chung Chang being referenced

MK-0626, A Dipeptidyl Peptidase-4 Inhibitor, Improves Neovascularization by Increasing Both the Number of Circulating Endothelial Progenitor Cells and Endothelial Nitric Oxide Synthetase Expression
2014
Dipeptidyl peptidase‐4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Nen‐Chung Chang 506 467 164 447 61 1.6k
Jacqueline Peynet 505 446 203 329 75 2.2k
Miyuki Kobara 544 473 327 271 68 1.9k
Ravi Nistala 641 526 338 776 58 2.1k
Fahimeh Varzideh 334 521 214 314 58 1.4k
Chiara Stranieri 476 511 261 285 52 1.8k
Mieko Minami 562 792 323 333 53 1.9k
Ivonne Hernandez Schulman 713 630 456 510 71 2.2k
Jérémy Bellien 617 380 358 338 74 1.8k
Tomoaki Shimizu 610 387 260 778 85 2.1k
Daiju Fukuda 727 486 217 327 96 1.9k

All Works

Loading papers...

Rankless by CCL
2026